2,5-dioxoimidazolidin-4-yl acetamines and analogues as inhibitors of metalloproteinase mmp12
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Apr 8, 2008
Grant Date -
Nov 3, 2005
app pub date -
Aug 26, 2003
filing date -
Aug 27, 2002
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The invention provides compounds of formula (I) in which L, X, Y, Z.sup.1, Z.sup.2, R.sup.1, R.sup.2, R.sup.3 and G.sup.2 have the meanings defined in the specification; processes for their preparation; pharmaceutical compositions containing them; a process for preparing the pharmaceutical compositions; and their use in therapy. The compounds of the invention are inhibitors of metalloproteinase MMP12 and are among other things useful for the treatment of obstructive airways diseases, such as asthma and chronic obstructive pulmonary disease (COPD).
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully